Last reviewed · How we verify
Anise-oil EC Capsule — Competitive Intelligence Brief
phase 3
Herbal carminative / digestive aid
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Anise-oil EC Capsule (Anise-oil EC Capsule) — Shiraz University of Medical Sciences. Anise oil acts as a carminative and anti-inflammatory agent that reduces gastrointestinal distension and promotes digestive comfort through its volatile oil constituents.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Anise-oil EC Capsule TARGET | Anise-oil EC Capsule | Shiraz University of Medical Sciences | phase 3 | Herbal carminative / digestive aid |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal carminative / digestive aid class)
- Shiraz University of Medical Sciences · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Anise-oil EC Capsule CI watch — RSS
- Anise-oil EC Capsule CI watch — Atom
- Anise-oil EC Capsule CI watch — JSON
- Anise-oil EC Capsule alone — RSS
- Whole Herbal carminative / digestive aid class — RSS
Cite this brief
Drug Landscape (2026). Anise-oil EC Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/anise-oil-ec-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab